Mean HbA1c for patients in the first to fourth randomised trials , averaged across diabetes category , decreased by trial ( 7.28 % , 6.92 % , 6.87 % and 6.64 % [ 56.1 , 52.1 , 51.6 and 49.1 mmol/mol ] , respectively ; p = 0.02 ) .